Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer

Prostate-specific antigen (PSA) has been widely used as a serum marker for prostate cancer (PCa) screening or progression monitoring, which dramatically increased rate of early detection while significantly reduced PCa-specific mortality. However, a number of limitations of PSA have been noticed. Lo...

Full description

Saved in:
Bibliographic Details
Published in:Am J Clin Exp Urol
Main Authors: Huang, Ya-Qiang, Sun, Tong, Zhong, Wei-De, Wu, Chin-Lee
Format: Artigo
Language:Inglês
Published: e-Century Publishing Corporation 2014
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297331/
https://ncbi.nlm.nih.gov/pubmed/25606581
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items